Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) Interest & Investment Income: 2020-2024

Historic Interest & Investment Income for Beauty Health (SKIN) over the last 5 years, with Dec 2024 value amounting to $16.6 million.

  • Beauty Health's Interest & Investment Income fell 74.24% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 53.60%. This contributed to the annual value of $16.6 million for FY2024, which is 28.18% down from last year.
  • Latest data reveals that Beauty Health reported Interest & Investment Income of $16.6 million as of FY2024, which was down 28.18% from $23.2 million recorded in FY2023.
  • Over the past 5 years, Beauty Health's Interest & Investment Income peaked at $23.2 million during FY2023, and registered a low of -$21.3 million during FY2020.
  • For the 3-year period, Beauty Health's Interest & Investment Income averaged around $16.3 million, with its median value being $16.6 million (2024).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 23,425.64% in 2022, then fell by 28.18% in 2024.
  • Beauty Health's Interest & Investment Income (Yearly) stood at -$21.3 million in 2020, then spiked by 100.18% to $39,000 in 2021, then skyrocketed by 23,425.64% to $9.2 million in 2022, then skyrocketed by 152.57% to $23.2 million in 2023, then dropped by 28.18% to $16.6 million in 2024.